Revolutionizing Alzheimer’s Care: CBD Life Sciences Launches Delta-8 Gummies

Revolutionizing Alzheimer’s Care: CBD Life Sciences Launches Delta-8 Gummies

A New Hope for Alzheimer’s Patients In a significant move aimed at the burgeoning $6 billion U.S. edibles market, CBD Life Sciences Inc. has unveiled its innovative Delta-8 100mg Gummies, designed specifically for individuals living with Alzheimer’s disease. With an anticipated $3 million in revenue within the first year, these gummies promise to offer relief […]

The post Revolutionizing Alzheimer’s Care: CBD Life Sciences Launches Delta-8 Gummies first appeared on CBD Telegraph.



* This article was originally published here

Comments

Popular posts from this blog

Could CBD Be the Natural Solution to Fever Relief?

cbdMD Extends Partnership with Spotify and Joe Rogan as Exclusive CBD Advertiser

Can Cannabis Help With Chronic Fatigue Syndrome?